Indigrid Infrastructure Trust (BOM:540565)
India · Delayed Price · Currency is INR | Market Cap | 130.23B |
| Revenue (ttm) | 34.06B |
| Net Income (ttm) | 3.37B |
| Shares Out | 834.56M |
| EPS (ttm) | 4.10 |
| PE Ratio | 38.06 |
| Forward PE | n/a |
| Dividend | 16.40 (10.50%) |
| Ex-Dividend Date | Jul 29, 2025 |
| Volume | 14,056 |
| Average Volume | 25,417 |
| Open | 156.05 |
| Previous Close | 156.05 |
| Day's Range | 155.20 - 156.70 |
| 52-Week Range | 134.35 - 158.53 |
| Beta | -0.01 |
| RSI | 53.38 |
| Earnings Date | Jul 23, 2025 |
About Theseus Pharmaceuticals
Indigrid Infrastructure Trust operates as an infrastructure investment trust that owns and operates power transmission, renewable generation, and energy storage assets in India. The company’s asset portfolio consists of portfolio assets consists of 41 power projects. It consists of 52 transmission lines with 9,060 circuit kilometres length, 15 substations with 22,550 MVA transformation capacity, 855 MW (AC) of solar generation capacity, and 450 MW / 900 MWh of battery energy storage capacity. The company was formerly known as India Grid Trust a... [Read more]
Financial Performance
In 2024, BOM:540565's revenue was 34.07 billion, an increase of 14.88% compared to the previous year's 29.66 billion. Earnings were 3.98 billion, an increase of 39.60%.
Financial StatementsNews
Esoteric II Pte to sell 17.32% stake in India Grid Trust via Offer For Sale
Esoteric II Pte, a sponsor of India Grid Trust, plans to sell up to 17.32% of its stake in the company through an Offer For Sale (OFS). The sale will take place over two days, August 22-23, 2024, with...